Lyft and Continuum Partner for Transportation Solutions
Chicago, IL – Today, Lyft and Continuum Clinical announced a partnership that will help to provide transportation solutions for patients who are enrolled in pharmaceutical clinical trials.
This partnership represents the first of its kind among pharmaceutical vendors who work on behalf of pharmaceutical companies to recruit patients for clinical trials.
“We’re thrilled to partner with Lyft to offer patients enrolled in clinical trials a new level of convenience,” said Nariman Nasser, vice president of site optimization at Continuum Clinical. “We believe that this service will make enrolling and staying in a study easier, especially for those patients with limited resources and access to transportation.”
Lack of transportation is frequently cited as a barrier to retaining patients in clinical trials. Through Continuum’s partnership with Lyft, patients enrolled in clinical trials will be able to use the Lyft app to secure transportation to and from the trial site, free of charge.
The program will help to ensure that patients enrolled in the trials won’t miss appointments, which may potentially disqualify them from the trial. Continuum plans on trialing the Lyft program this quarter for a national study on lupus.
“Through our partnership with Continuum Clinical, we’re able to provide patients with safe, affordable and reliable rides,” said Gyre Renwick, head of enterprise healthcare partnerships at Lyft. “We look forward to working with Continuum to help the community get around more efficiently.”
In 2016, Lyft partnered with a number of senior care providers and healthcare systems for non-emergency transportation services. Continuum Clinical will be a preferred provider for clinical trial transportation solutions.
For over 20 years, Continuum Clinical has worked with eight of the top ten pharmaceutical companies around the world to recruit patients for clinical trials through integrated marketing efforts. They have recruited patients for more than 600 studies in over 75 disease states. Currently, Continuum is working with over 1,900 active study sites throughout the U.S.
About Continuum Clinical
Continuum Clinical is a global healthcare research and communications company. With over thirty years of experience, Continuum Clinical brings together a unique blend of world-class experience in key disciplines, including observational research, marketing, communications, site optimization health economics, and outcomes research. We excel in providing seamless resources for pharmaceutical and biotech products - from patient recruitment and retention for clinical trials to late stage studies and health economics and outcomes research. Continuum Clinical provides a unique blend of resources and perspectives, proven expertise, and innovative solutions throughout the entire continuum of a product’s lifecycle - from pre-launch into the real world. Headquartered in the US, Continuum Clinical has employees in Europe and expanded worldwide network of resources. www.continuumclinical.com.
About Lyft
Lyft was founded in June 2012 by Logan Green and John Zimmer to improve people's lives with the world's best transportation. Lyft is the fastest growing rideshare company in the U.S and is available in more than 200 cities. Lyft is preferred by drivers and passengers for its safe and friendly experience, and its commitment to effecting positive change for the future of our cities. For more information on Lyft for Healthcare, visit http://get.lyft.com/healthcare/
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
